During the secondment, I used the MACS® Matchmaker to measure antibody responses in plasma samples from patients with ALK-positive anaplastic large cell lymphoma (ALK+ ALCL).
Read More
Today, we expect much more from doctoral students than just good research. They must also be skilled in marketing and understand the legal aspects.
Read More
After months of generating data in the lab, my secondment at Open Science – Lebenswissenschaften im Dialog in Vienna was a refreshing change of perspective, and a reminder of why science communication matters.
Read More
During May I attended two engaging conferences where I had the opportunity to present the latest update of my research on Anaplastic Large Cell Lymphoma.
Read More
During my time in the Merkel lab in Vienna, I investigated lipid metabolism in anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL).
Read More
My research focuses on why patients with the same type of cancer can respond very differently to the same treatment. One key reason appears to be the body’s own defense system
Read More
My PhD research focuses on understanding how cancer cells evolve during treatment, particularly how they become resistant to targeted therapies over time. I study a type of childhood cancer called ALK-positive Anaplastic Large Cell Lymphoma
Read More
Working in Professor Lena Illert’s laboratory and closely alongside Magdalena, I worked with clinical ALK+ ALCL patient samples using the PhenoCycler-Fusion 2.0 system (Akoya Biosciences).
Read More
My research focuses on understanding how and why people get cancer. Specifically, I study two subtypes of a rare immune cell cancer called Anaplastic Large Cell Lymphoma (ALCL). In this disease, T cells that are usually protecting the body
Read More
This experience has been incredibly valuable both scientifically and professionally. During my time at Suzanne Turner’s Lab in the Department of Pathology, University of Cambridge, I had the opportunity to work closely
Read More